Value of oxygen therapy in end-of-life care challenged in new study
Millions of patients with advanced disease in palliative care settings receive oxygen therapy to help them breathe more easily. But a new study says roughly half of them don’t benefit from the intervention, and among those who do benefit, it doesn’t make a bit of difference whether they get pure oxygen or just plain old room air — both offer equal benefit.
The first of my “Cancer Series”, redone completely. My mom was diagnosed with small cell lung cancer (from prolonged smoking); it was, at first, in her lungs & lymphnodes in her neck. It was inoperable, so they did chemo & preventative radiation on her brain. A year later she was in hospice… RiP Mom (March 12, 1950 – April 15, 2003) Thanks for watching… and please – don’t smoke. [Music] “loss” by Kevin MacLeod [Tobacco Research] – www.quitsmokingsupport.com – www.lungusa.org – quitsmoking.about.com — Kat @ MKP [ www.youtube.com ]
The V Foundation for Cancer Research Awards 2010 Translational Grants Triangle – The V Foundation for Cancer Research, one of the nation’s leading cancer research fundraising organizations, announced today it has awarded the 2010 Translational grants to elite researchers across the United States. Read more on dBusinessNews.com
Ex-Fernald workers can get free tests The coordinator of a program that offers free health exams for people who used to work at the old uranium foundry is trying to get the word out about an early lung cancer detection program. Read more on The Cincinnati Enquirer
the WSJ is reporting that Pfizer Inc. (PFE) said its cancer treatment Sutent failed to meet its endpoint of improving overall survival for late-stage lung cancer in a late-stage trial, although it did improve progression-free survival. Sutent, also known as sunitinib, has been one of Pfizer’s more successful drugs to launch in recent years. Approved [...]
An innovative clinical trial uses tumor biopsy information and unique statistical method to match four drugs to potential biomarkers that might guide treatment. Study leader Dr. Edward Kim of The University of Texas MD Anderson Cancer Center discusses BATTLE results.